Ouabain Effects on Human Anaplastic Thyroid Carcinoma 8505C Cells

Mariana Pires Teixeira1,2,3,4, Natalia Ferreira Haddad4,5, Eliza Freitas Passos5

  • 1Laboratório de Imunorregulação, Departamento de Imunobiologia, Instituto de Biologia, Universidade Federal Fluminense, Niterói 24210-201, Brazil.

Cancers
|December 23, 2022
PubMed

Insights

Ouabain may inhibit anaplastic thyroid carcinoma (ATC) cell proliferation and migration. However, this cardiotonic steroid treatment did not alter the aggressive, undifferentiated profile of these aggressive thyroid cancer cells.

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Anaplastic thyroid carcinoma (ATC) is an aggressive thyroid cancer with high mortality.
  • Current treatments offer limited efficacy, necessitating novel therapeutic strategies.
  • Cardiotonic steroids, like ouabain, show promise as anti-cancer agents.

Purpose of the Study:

  • To investigate the therapeutic potential of ouabain in human anaplastic thyroid carcinoma (ATC) cells.
  • To evaluate the effects of ouabain on 8505C cell viability, proliferation, and migration.
  • To assess ouabain's impact on differentiation and epithelial-to-mesenchymal transition (EMT) markers in ATC cells.

Main Methods:

  • Human 8505C anaplastic thyroid carcinoma cells were cultured with or without ouabain.
  • Assessed cell viability, death, cell cycle, colony formation, and migratory ability.
  • Quantified mRNA expression of differentiation markers (PAX8, TTF1), EMT markers (N-cadherin), and related signaling molecules (IL-6, TGFb1).

Main Results:

  • Ouabain treatment reduced the viability and proliferation of 8505C cells in vitro.
  • A significant decrease in cell migration was observed in ouabain-treated cells.
  • Ouabain decreased differentiation markers (PAX8, TTF1) and increased EMT marker (N-cadherin) and pro-inflammatory cytokines (IL-6, TGFb1) mRNA levels.

Conclusions:

  • Ouabain exhibits anti-proliferative and anti-migratory effects on anaplastic thyroid carcinoma cells.
  • Despite these effects, ouabain treatment did not reverse the undifferentiated and aggressive phenotype of ATC cells.
  • Further research is needed to explore ouabain's complex role in ATC treatment.